Investment Rating - The report maintains a "Buy" rating for the cosmetics and medical beauty sector, highlighting the potential for growth despite recent underperformance compared to the market [2]. Core Insights - The cosmetics and medical beauty sector has shown weaker performance compared to the market, with the Shenwan Beauty Care Index declining by 3.0% from February 27 to March 6, 2026. The Shenwan Cosmetics Index fell by 4.9%, underperforming the Shenwan A Index by 2.5 percentage points [3][2]. - Upbeauty Co., Ltd. has reported a positive earnings forecast for 2025, with expected revenue between 9.1 billion and 9.2 billion yuan, representing a year-on-year increase of 34.0% to 35.4%. The expected net profit attributable to shareholders is projected to be between 1.14 billion and 1.16 billion yuan, reflecting a growth of 41.9% to 44.4% [8][2]. - The report emphasizes the strong brand and product capabilities of Upbeauty, which are expected to support its performance in the short term, while its diversified layout and solid industry barriers are seen as beneficial for long-term growth [8][2]. Summary by Sections Industry Performance - The cosmetics and medical beauty sector has underperformed the market recently, with specific indices showing declines [3][2]. - The report notes that the overall retail sales of cosmetics in December 2025 grew by 8.8%, indicating a recovery in consumer spending [16][19]. Company Highlights - Upbeauty Co., Ltd. is highlighted for its strong performance, with a focus on anti-aging products that align with consumer trends towards domestic brands [8][2]. - Huaxi Biological's earnings report indicates a net profit of 291 million yuan for 2025, a significant increase of 67.03% year-on-year, showcasing the effectiveness of its strategic transformation [2][21]. - Yatsen E-commerce reported a revenue of 1.38 billion yuan in Q4 2025, marking a 20.1% increase year-on-year, with skincare being the main growth driver [21][2]. Market Trends - The report identifies a structural growth phase in the nutrition and health food market, with a focus on functional foods and sports nutrition as key growth areas [10][9]. - The Chinese skincare market is projected to reach 271.2 billion yuan in 2024, despite a slight decline of 3.7% year-on-year, with domestic brands gaining market share [25][26]. E-commerce Insights - The report highlights the dominance of online channels in driving growth within the industry, with a significant portion of revenue coming from direct-to-consumer (DTC) sales [10][9]. - The performance of various domestic brands in e-commerce platforms is noted, with Upbeauty showing substantial growth in its online sales [13][2].

Core Viewpoint - Estée Lauder Companies is experiencing a decline in sales and operating profit, with a net sales drop of 8.2% year-over-year for the fiscal year ending June 30, 2025, and an operating loss of $785 million, indicating a challenging recovery ahead [1][2][3]. Financial Performance - The company reported net sales of $14.33 billion for fiscal year 2025, down from $15.61 billion in the previous year, reflecting an overall decline of 8% [2][8]. - The operating loss for the fiscal year was $785 million, a significant decrease from an operating income of $970 million in the prior year [2][10]. Business Segment Performance - Skin Care: Net sales decreased by 12% to $6.96 billion, primarily due to declines in brands like Estée Lauder and La Mer, with significant impacts from market shifts in South Korea and China [3][4]. - Makeup: Sales fell by approximately 6% to $4.21 billion, with brands like M·A·C and Bobbi Brown showing retail weakness [4]. - Hair Care: Net sales dropped by 10% to $565 million, attributed to poor performance from the Aveda brand and challenges in offline retail channels [4][5]. - Fragrance: This segment was the only one to show growth, with net sales of $2.49 billion, a slight increase of 0.16%, driven by strong performance from Le Labo [4]. Regional Performance - The Americas: Net sales were $4.41 billion, down 4% year-over-year [8]. - EMEA: The largest market for Estée Lauder, with net sales of $5.38 billion, saw a 12% decline [7][8]. - Asia Pacific: Experienced a significant drop of 21% in net sales to $3.61 billion, with China specifically reporting a 5.6% decline [8][9]. Future Outlook - The company is optimistic about returning to organic sales growth in fiscal year 2026, particularly in the Chinese market, which is expected to see mid-single-digit growth [6][10]. - Estée Lauder plans to implement a restructuring strategy aimed at achieving $800 million to $1 billion in pre-tax benefits annually, which will help restore operating profit margins and support reinvestment in consumer-facing areas [10].

Core Insights - Yatsen E-commerce reported a revenue of 1.09 billion yuan for Q2 2025, representing a year-on-year growth of 36.8% [1] - The skincare segment saw a significant increase, with revenue rising by 78.7% to 580 million yuan, accounting for 53.5% of total revenue, marking a historical high for quarterly revenue contribution [1] - Gross profit for Q2 increased by 39.5%, with a gross margin rising to 78.3% [1] - Non-GAAP net profit turned positive at 11.5 million yuan, indicating sustained profitability on a Non-GAAP basis [1] - The company has achieved three consecutive quarters of positive revenue growth, while maintaining a Non-GAAP profit [1] - R&D expenses reached 36.12 million yuan, representing 3.3% of total revenue, with R&D expense ratio exceeding 3% for three consecutive years [1]